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ABSTRACT
Predicting the T-cell-mediated immune response is
an important task in vaccine design and thus one of
the key problems in computational immunomics.
Various methods have been developed during the
last decade and are available online. We present
EpiToolKit, a web server that has been specifically
designed to offer a problem-solving environment for
computational immunomics. EpiToolKit offers a
variety of different prediction methods for major
histocompatibility complex class I and II ligands as
well as minor histocompatibility antigens. These
predictions are embedded in a user-friendly inter-
face allowing refining, editing and constraining the
searches conveniently. We illustrate the value of the
approach with a set of novel tumor-associated
peptides. EpiToolKit is available online at www.
epitoolkit.org.
INTRODUCTION
Prediction of T-cell epitopes is a key problem in Immuno-
informatics (1). Identifying peptides with high binding
aﬃnity to major histocompatibility complex (MHC) mole-
cules is generally considered the best way to predict
epitopes (2). Many diﬀerent methods and tools for
peptide–MHC binding have been developed in the recent
past, most of them are accessible online (3–12). Most of the
individual web servers, however, were designed to quickly
oﬀer online access to a newly developed method with
usability not being the major concern. Nonexpert users
may be overwhelmed by the variety of layouts, formats
and options.
The main focus in the development of the EpiToolKit
web server was usability. The purpose of EpiToolKit is to
facilitate immunological research by providing a con-
sistent and user-friendly interface for diﬀerent methods
from computational immunomics. The prediction pipeline
is organized in four main steps: sequence input, sequence
information, model selection and display of prediction
results. Each page contains hints and short comments to
guide the user through the pipeline. In addition, a detailed
help and documentation is available through direct links
on every page.
The service provides most of the commonly accepted
prediction methods and allows their simultaneous applica-
tion. Thereby, prediction results can be compared without
the need to access the individual web-based services sepa-
rately. The combination of diﬀerent prediction methods
also increases the number of available allelic models.
In addition to epitope prediction, EpiToolKit oﬀers the
functionality to examine the inﬂuence of sequence poly-
morphisms or mutations on potential T-cell epitopes. This
feature is useful for the identiﬁcation of minor histocom-
patibility antigens (mHags) and for the development of
peptide-based vaccines against highly variable pathogens
such as HCV and HIV.
EpiToolKit is based on a ﬂexible and modular frame-
work for predictions related to epitope prediction (13).
The framework and EpiToolKit can easily be extended
with new methods—e.g. new methods for MHC binding,
or for the prediction of the epitope processing pathway.
WEB INTERFACE
The web interface is divided into two parts, the epitope
prediction and the prediction on polymorphic proteins
(SNEPv2). Both predictions use the same layout and are
based on a common pipeline. To facilitate the use of
EpiToolKit, the prediction pipeline has been broken down
into four intuitive steps:
(1) Sequence input. Sequences can be retrieved from the
most important resources for protein sequences,
namely Swiss-Prot (14) and NCBI RefSeq (15).
In case of polymorphic prediction, all reported
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vided automatically. Alternatively, the user can paste
sequences directly or upload a FASTA ﬁle. In case of
user-deﬁned polymorphic or mutated sequences, the
changes can be speciﬁed in the FASTA header.
(2) Sequence information. The purpose of this step is to
present the query results for the requested sequences.
For all returned sequences, additional information
such as sequence length, GeneID or RefSeq accession
is displayed. Furthermore, SNEPv2 returns all anno-
tated polymorphisms for each sequence. The sequences
as well as the polymorphisms can be selected or
deselected individually for further processing.
(3) Allele selection. In this step, the user can select allelic
models for prediction. The model selection is orga-
nized in an expandable model/allele tree, sorted by
allele name. The tree can be customized to contain
only models for selected peptide lengths, prediction
methods or alleles in the advanced options section.
(4) Prediction results. Results are displayed as tables.
For epitope prediction, a single table is created for
every peptide length. In case of polymorphic pre-
dictions using SNEPv2 for each polymorphism a
separate table is created. Diﬀerent methods for dis-
crimination between predicted binders and nonbinders
are available. Filter and display options can be
changed in the advanced options section. Additionally,
the prediction results can be exported in CSV (comma
separated values) or XLS (Microsoft Excel) format.
DATASETS
EpiToolKit provides access to the Swiss-Prot database
(14) and the NCBI RefSeq database (15). To improve the
reliability of the service and to accelerate access time, both
databases are kept as local copies. They are updated
monthly. Current release information is displayed on the
sequence input site.
Polymorphism information is provided from two
diﬀerent sources depending on the database used for
sequence retrieval. For RefSeq sequences, polymorphisms
are obtained from dbSNP (16). SNP entries contain links
to protein sequences if the corresponding variation has
been mapped onto coding regions. For requested RefSeq
sequences, nonsynonymous coding SNPs are yielded by
EpiToolKit. Furthermore, to limit the search to relevant
polymorphisms the set of reported polymorphisms can
be restricted to a user-deﬁned heterozygosity range.
Polymorphisms for Swiss-Prot sequences are extracted
directly from the Swiss-Prot entries. Polymorphism data
from dbSNP as well as from Swiss-Prot are also kept in
local databases.
IMPLEMENTATION
This section brieﬂy describes the prediction methods
included in EpiToolKit and the implementation of the
web server.
Prediction on polymorphic proteins
In addition to epitope prediction EpiToolKit provides the
possibility to perform predictions on proteins containing
polymorphisms. This tool is called SNEPv2. It is a new
version of the SNP-derived Epitope Prediction program
(SNEP) developed by Schuler et al. (11). One major
improvement of SNEPv2 is the use of a second resource to
retrieve sequence polymorphisms [dbSNP (16)]. Addition-
ally, due to the embedding into EpiToolKit, SNEPv2
oﬀers a comfortable user interface. The latter enables
users to perform predictions for multiple polymorphic
sequences from several sources, to apply a variety of
prediction methods and to use diﬀerent ﬁltering methods
to restrict the result set.
SNEPv2 creates a set of polymorphic peptides for each
reported sequence polymorphism. These peptide sets are
generated by extracting the peptides around the poly-
morphic position using a sliding window of speciﬁed
length and subsequently mutating these peptides to all
observed variants. The prediction results are displayed
separately for each peptide set. On the result page, the user
can additionally switch between the epitope prediction
results for the source protein and the polymorphic
predictions.
Epitope prediction methods
A major challenge in epitope prediction is that the
manifold MHC alleles display a wide spectrum of binding
speciﬁcities. Prediction methods must therefore provide
models for diﬀerent alleles. Not all prediction methods
have a model for every allele or peptide length.
Five diﬀerent methods for the prediction of peptides
binding to MHC class I and two methods for MHC class
II binding are currently available in EpiToolKit. These
methods are described brieﬂy in the following. For details
on the prediction methods refer to the original publica-
tions. A table of all available allelic models and methods
can be found in Supplementary Material 1. The descrip-
tion of the available methods in the documentation of
EpiToolKit will be updated when new methods are
included into EpiToolKit.
 SYFPEITHI (3) is based on position-speciﬁc scoring
matrices. The matrices are manually generated based
on expert knowledge and the occurrence of amino
acids in naturally processed MHC ligands from the
SYFPEITHI database.
 BIMAS/HLA_BIND (4) was developed at the
BioInformatics and Molecular Analysis Section
(BIMAS) at the NIH. The prediction method uses
position speciﬁc scoring matrices that are derived from
experimentally determined relative binding aﬃnities.
Dissociation rates of peptide:MHC:b2-microglobulin
complexes are used to measure binding aﬃnities rela-
tive to a reference peptide. The original values in the
matrices are log-transformed to obtain an additive
scoring scheme.
 SVMHC (5) uses support vector machine classiﬁ-
cation to predict MHC-binding peptides. The method
is trained on known MHC-binding peptides from
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nonbinders.
 Epidemix (13) is based on position-speciﬁc scoring
matrices. The matrices are statistically computed based
on the positive training set of SVMHC. Sequence
weighting and pseudo-count correction are applied to
obtain the frequencies used to generate the matrices.
 UniTope (Feldhahn, Toussaint, Ziehm, and
Kohlbacher, manuscript in preparation) is a support
vector classiﬁcation method recently developed in our
group. UniTope combines structural and sequence
information in a machine-learning framework. Based
on a decomposition of the MHC-binding groove into
distinct pockets, the correlation between the physico-
chemical properties of these pockets and peptide binding
is learned. The allele encoding uses pocket proﬁles
derived from crystal structures of peptide:MHC com-
plexes. The peptides are also encoded using physico-
chemical properties. This enables binding prediction
even for alleles where no experimental binding data are
available.
 Hammer (17) is based on position-speciﬁc scoring matri-
ces and predicts binding peptides for MHC class II.
The virtual matrices were published by Sturniolo et al.
(17) and are used by the TEPITOPE software.
 MHCIIMulti (18) is a new method based on multiple
instance learning and support vector classiﬁcation,
which can be used to predict peptide binding for MHC
class II. Therefore, a new kernel is introduced, which
also takes similarities between alleles into account.
The method can even be used to predict binding pep-
tides for alleles without available binding data.
Filtering methods
Most prediction methods predict a score that represents
the binding aﬃnity of a peptide to an MHC allele. In
order to discriminate binding peptides from nonbinding
peptides, a threshold can be used to separate binders from
nonbinders.
EpiToolKit uses thresholds to ﬁlter the results for
potential epitopes. Only peptides classiﬁed as binders
are displayed if a ﬁlter is activated. The following ﬁlter
options are available:
(1) No ﬁltering. All predicted scores are displayed. The
peptides are not classiﬁed as binders or nonbinders.
(2) Filtering using halfmax-scores. For all matrix-based
methods, the halfmax-score is deﬁned as half of
the maximal value obtainable from the matrix. The
halfmax-scores are used as thresholds. For SVM-
based predictions halfmax-scores are not deﬁned.
The 2%-thresholds are used instead (see ‘Filtering by
percentage’ subsequently). The halfmax ﬁlter is the
default ﬁlter method in EpiToolKit.
(3) Filtering by percentage. The thresholds are deter-
mined based on a background score distribution that
was computed on a large set of peptides derived from
natural proteins. The thresholds can be interpreted
as follows: using as example a 2%-threshold 2% of
the peptides used to compute the background
distribution would be classiﬁed as binders. The
advantage of this ﬁltering method is that—in
contrast to the halfmax-ﬁltering—thresholds for
diﬀerent allelic models are comparable. The input
format for the percentage thresholds is a ﬂoat in the
interval of [0, 1], e.g. 0.02 for a 2%-threshold.
Note that the current version of UniTope performs a
binary classiﬁcation. For consistency, all ﬁlter methods
are also available for UniTope predictions but do not have
an inﬂuence on the classiﬁcation—peptides with score 1
are always classiﬁed as binders, whereas peptides with
score 0 are always classiﬁed as nonbinders.
Webserver
EpiToolKit utilizes the open source content management
framework Plone (http://plone.org) based on the applica-
tion server Zope (http://www.zope.org). Dynamic HTML
pages provide forms for user input and prediction results.
The pages use CSS and JavaScript and the service was
tested for compatibility with the two most widely used web
browsers, namely Mozilla Firefox (version 2.0) and MS
Internet Explorer (version 7). Input data is pre-processed
by Python scripts for data validation. Entered user data
are temporarily stored on the server and automatically
deleted after the corresponding session has expired. The
program logic for data processing and for performing
epitope prediction (13) is written in Python. Several tasks
of the program logic use the Biopython package (http://
biopython.org).
VALIDATION AND APPLICATION
To validate the correct function of EpiToolKit, the
prediction results for 1000 randomly chosen proteins
were compared to the results of the original methods/web
servers. In all cases EpiToolKit produced the same results
as the original methods.
In addition, a set of 27 novel HLA-A
0201 ligands
characterized from tumor cells and in part derived from
tumor antigens were used for validation. These peptides
are listed in Supplementary Material 2. All available allelic
models of appropriate length were used for prediction and
default ﬁltering (halfmax) was applied. Eighteen out of 20
nonameric peptides and six out of seven decameric
peptides were correctly classiﬁed as binders.
To validate SNEPv2, we tried to retrospectively identify
the mHags reported by Goulmy (19). The paper gives an
introduction to the clinical relevance of mHags and
contains a list of all then known human mHags. We
refer to the single mHags with the names used in (19). The
dataset is available in Supplementary Material 3.
Eight out of nine autosomally encoded mHags reported
could directly be found using SNEPv2. The HLA-A
2902
restricted mHag UGT2B17 results from a gene-deletion
and therefore no allelic counterpart is available, so epitope
prediction was used. Since no decameric model was
available for HLA-A
2902, the nonameric UniTope
model was used to score the two nonameric substrings.
Both substrings were predicted to bind to HLA-A
2902.
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counterparts, except for the HLA-A
01 restricted mHag
DFFRY. Both versions of DFFRY were predicted to bind
to HLA-A
0101. For all other Y-chromosomal mHags,
epitope prediction was used. RPS4Y/HLA-DRB3
0301
was correctly classiﬁed as binder. No allelic model was
available to predict the mHag DBY/HLA-DQ. For
two gonosomal mHags (UTY/HLA-B60 and SMCY/
HLA-B7), no model of the appropriate length was
available, so all related models of shorter length were
used. For both mHags, at least one nonameric substring
was predicted to bind by the respective model. The
remaining three mHags were correctly predicted to bind to
the restricting allele.
These examples demonstrate the usefulness and applic-
ability of EpiToolKit for the identiﬁcation of potential
epitopes and mHags.
CONCLUSION
As a convenient and user-friendly program, EpiToolKit
enables the direct comparison of diﬀerent epitope predic-
tion software packages and thus allows for precise
selection of HLA-presented peptides from any protein of
choice. In addition, its unique feature of screening
polymorphic proteins for HLA ligands with SNEPv2
will promote and facilitate the identiﬁcation of mHags,
including tissue-speciﬁc peptides, as well as epitopes from
quickly mutating pathogens. We expect that EpiToolKit
with its epitope prediction and in particular with the
SNEPv2 screening will provide valuable support in the
future identiﬁcation of T cell epitopes of major clinical
relevance.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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